| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/12/2013 | CN102440973B Diphenhydramine citrate orally disintegrating tablet and preparation method thereof |
| 06/12/2013 | CN102406610B Particle dosing system with long circulation performance and preparation method thereof |
| 06/12/2013 | CN102397555B Veterinary use soluble powder accessory and preparation method thereof |
| 06/12/2013 | CN102379843B Levocarnitine pharmaceutical composition for injection |
| 06/12/2013 | CN102357184B Traditional Chinese medicine preparation for treating cough and preparation method thereof |
| 06/12/2013 | CN102350278B Preparation of drug-carrying chitosan microspheres |
| 06/12/2013 | CN102335137B Medicinal composition containing meropenem |
| 06/12/2013 | CN102335136B Meropenem medicinal composition for injection and preparation method thereof |
| 06/12/2013 | CN102309562B Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 06/12/2013 | CN102271658B Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
| 06/12/2013 | CN102266566B Magnetic compound, and preparation method and purpose thereof |
| 06/12/2013 | CN102258489B Dextromethorphan chewing gum tablets and preparation method thereof |
| 06/12/2013 | CN102228442B Star-like macromolecule nanometer microsphere and preparation method and application thereof |
| 06/12/2013 | CN102215817B Pharmaceutical composition containing prostaglandin |
| 06/12/2013 | CN102204893B Blonanserin dropping pill and preparation method thereof |
| 06/12/2013 | CN102164586B Oral preparation |
| 06/12/2013 | CN102159189B Nanocarriers for drug delivery |
| 06/12/2013 | CN102149374B Orally administrable formulation containing branched chain amino acid |
| 06/12/2013 | CN102125696B Oligomeric ribonucleic acid composite for inhibiting tumor growth and angiogenesis and application thereof |
| 06/12/2013 | CN102125547B Pharmaceutical composition containing gambogic acid medicament and preparation method thereof |
| 06/12/2013 | CN102113996B Oral formulations containing protein or peptide, and preparation method and application thereof |
| 06/12/2013 | CN102078284B Gatifloxacin-containing gel for eyes and preparation method thereof |
| 06/12/2013 | CN102000344B Medicament coating composition with masked taste |
| 06/12/2013 | CN101980725B Prodrug comprising a drug linker conjugate |
| 06/12/2013 | CN101897666B Pazufloxacin mesilate injection preparation and detection method thereof |
| 06/12/2013 | CN101890121B External medicinal composition for treating acute soft tissue injury and preparation method and application thereof |
| 06/12/2013 | CN101889958B Freeze-dried composition |
| 06/12/2013 | CN101870735B High-glycosylation erythropoietin immune fusion protein |
| 06/12/2013 | CN101857666B Cellulose ether grafted and modified temperature-sensitive hydrogel and preparation method thereof |
| 06/12/2013 | CN101818044B Organogel of dipeptide-like and preparation method thereof |
| 06/12/2013 | CN101797221B Oral drug delivery system comprising high viscosity liquid carrier materials |
| 06/12/2013 | CN101757522B Swelling reducing and pain easing gel and preparation method thereof |
| 06/12/2013 | CN101747461B Polymer containing hydroxystyrene on side group, preparation method and application thereof |
| 06/12/2013 | CN101721456B Antiatherosclerotic Chinese traditional medicine for treating cardiovascular and cerebrovascular diseases and method for preparing phospholipid complex formulation thereof |
| 06/12/2013 | CN101652081B Liquid nutritional composition containing sodium at high concentration and method of producing the same |
| 06/12/2013 | CN101574373B Toad venom alcohol plastid and preparation method thereof |
| 06/12/2013 | CN101554368B Tetrodotoxin composition formulation stable at room temperature and used for injection |
| 06/12/2013 | CN101466737B Targeted binding agents directed to uPAR and uses thereof |
| 06/12/2013 | CN101437852B Anti-TAT226 antibodies and immunoconjugates |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101401799B Method for preparing farina microcapsule medicament |
| 06/12/2013 | CN101190248B Long chain fatty milk in camelina sativa oil orally-administered or injection preparations |
| 06/11/2013 | US8461410 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 06/11/2013 | US8461372 Amino acid derivatives and absorbable polymers therefrom |
| 06/11/2013 | US8461228 Ink composition, ink set and image forming method |
| 06/11/2013 | US8461213 Thickeners based on polyurethane |
| 06/11/2013 | US8461203 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/11/2013 | US8461136 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 06/11/2013 | US8461133 Inclusion complexes containing an active substance, a cyclodextrin and an agent for interaction |
| 06/11/2013 | US8461119 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 06/11/2013 | US8461116 Liquid composition of factor VII polypeptides |
| 06/11/2013 | US8461105 Polymer-based sustained release device |
| 06/11/2013 | US8460709 Pharmaceutical microparticles |
| 06/11/2013 | US8460708 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 06/11/2013 | US8460707 Stabilised prostaglandin composition |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | US8460676 Composition comprising VLP and amyloid beta peptide |
| 06/11/2013 | US8460663 Stabilized liquid anti-RSV antibody formulations |
| 06/11/2013 | US8460644 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 06/11/2013 | US8460640 Narcotic drug formulations with decreased abuse potential |
| 06/11/2013 | CA2777015C Film coating agent for solid preparation, and solid preparation using same |
| 06/11/2013 | CA2559161C Irna agents targeting vegf |
| 06/11/2013 | CA2519418C New injectable formulations containing progesterone |
| 06/11/2013 | CA2513388C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2491484C Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2437064C Storage-stable, liquid fibrinogen formulation |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/11/2013 | CA2400410C Antimicrobial compounds and formulations |
| 06/11/2013 | CA2363705C Devices and methods for pain management |
| 06/06/2013 | WO2013082504A1 Bioavailability enhancement delivery composition |
| 06/06/2013 | WO2013082470A1 Amphipathic lipid-based sustained release compositions |
| 06/06/2013 | WO2013082458A1 Reperfusion protection solution and uses thereof |
| 06/06/2013 | WO2013082418A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
| 06/06/2013 | WO2013082389A1 Mmp-targeted therapeutic and/or diagnostic nanocarriers |
| 06/06/2013 | WO2013082286A1 Peptide-mediated delivery of active agents across the blood-brain barrier |
| 06/06/2013 | WO2013082230A1 Imido-acid salts and methods of use |
| 06/06/2013 | WO2013082196A1 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF |
| 06/06/2013 | WO2013082149A1 Polysaccharide therapeutic conjugates |
| 06/06/2013 | WO2013082114A1 Use of p3 of bacteriophage as amyloid binding agents |
| 06/06/2013 | WO2013081566A1 A formulation comprising benzimidazole |
| 06/06/2013 | WO2013081217A1 Surface-modified ultraviolet blocking powder and ultraviolet blocking composition including same |
| 06/06/2013 | WO2013081120A1 Lecithin-organogel-forming agent |
| 06/06/2013 | WO2013081102A1 Ropinirole-containing adhesive patch |
| 06/06/2013 | WO2013081091A1 Drug for producing radiolabeled polypeptide reducing non-specific renal accumulation |
| 06/06/2013 | WO2013081044A1 Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindole-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonic acid hydrate |
| 06/06/2013 | WO2013081023A1 Reducing agent containing sodium borohydride |
| 06/06/2013 | WO2013081014A1 Adhesive skin patch |
| 06/06/2013 | WO2013080830A1 Cooling agent and trpm8 activator |
| 06/06/2013 | WO2013080271A1 Analgesic |
| 06/06/2013 | WO2013080265A1 Stabilization of s-adenosylmethionine with acid sodium metaphosphate |
| 06/06/2013 | WO2013080133A1 Fluorinated hydrophobin and uses thereof |
| 06/06/2013 | WO2013080028A1 Composition based on ubidecarenone |
| 06/06/2013 | WO2013078998A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
| 06/06/2013 | WO2013078769A1 Conjugate of polyethylene glycol and tamsulosin and pharmaceutical composition thereof |
| 06/06/2013 | WO2013078554A1 Compositions of tigecycline and uses thereof |
| 06/06/2013 | WO2013049521A3 Light-enabled drug delivery |